The Great American Read is made possible by the Anne Ray Foundation and public television viewers. Additional engagement funding for The Great American Read is made possible by CPB.

Moxetumomab pasudotox (formerly CAT-8015 or HA22) is an investigational anti-CD22 recombinant immunotoxin and a potential new medicine with the opportunity to be a first-in-class treatment in the US ...